Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.
Dalmases A, González I, Menendez S, Arpí O, Corominas JM, Servitja S, Tusquets I, Chamizo C, Rincón R, Espinosa L, Bigas A, Eroles P, Furriol J, Lluch A, Rovira A, Albanell J, Rojo F.
Dalmases A, et al. Among authors: albanell j.
Oncotarget. 2014 Jan 15;5(1):196-210. doi: 10.18632/oncotarget.1556.
Oncotarget. 2014.
PMID: 24344116
Free PMC article.